NDCVF News Alert Nordic Vlsi As (NDCVF) 7.3500 02/15/2015 05

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nordic Vlsi As (NDCVF) 7.3500 $NDCVF

Bluetooth Smart & Smart Ready Market Report: Automotive, Consumer Electronics, Wearable Electronics, Healthcare, and Building & Retail - Global Forecast to 2020
M2 - Fri Jan 16, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/r4hr3t/bluetooth_smart) has announced the addition of the "Bluetooth Smart & Smart Ready Market by Application, & Geography - Global Forecast to 2020" report to their offering. Bluetooth Low Energy (BLE) also known as Bluetooth Smart is a wireless personal area network (WPAN) topology designed and promoted by Bluetooth Special Interest Group (SIG). The technology is targeted at novel applications in health and wellness, sports and fitness, consumer electronics, appcessories and building automation applications. Rising demand for smartphones, tablets and wearable devices known as appcessories is expected to drive this market. The market associated with the Bluetooth Smart and Smart Ready is poised for tremendous growth. Applications such as automotive infotainment, wearable electronics, and healthcare among others are expected to be the high growth sectors with regards to implementation of this technology. This report covers the overall market on the basis of different types of devices, application, and geography. The major applications considered for this study are automotive, consumer electronics, wearable devices, healthcare, appcessories and building automation. Each of these applications is further segmented on the basis of different types of devices used in these applications. Considering the geographical scenario of the Bluetooth Smart and Smart Ready market, APAC occupied the top position, followed by Americas in 2013. The APAC region is also expected to exhibit the fastest growth, during the forecast period between 2014 and 2020. Some of the major industry players in the Bluetooth Smart and Smart Ready market are Broadcom Corporation (U.S.), Texas Instruments (U.S.), Cypress Semiconductor Corporation (U.S.), Nordic Semiconductor ASA (Norway), CSR Plc. (U.K.), Qualcomm Inc. (U.S.), and MediaTek Inc. (Taiwan) among others. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Cover Story - Bluetooth Sig (Special Interest Group) 5 Premium Insights 6 Market Overview 7 Industry Trends 8 Market, By Device Type 9 Market, By Application 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/r4...ooth_smart
CY: 14.76 (+0.01), TXN: 57.97 (+0.53), QCOM: 70.88 (+0.49)

Seaspan Reports Exercise of Underwriters' Option to Purchase 400K Additional 8.25 percent Series E Cumulative Redeemable Perpetual Preferred Shares
Close-Up Media - Thu Feb 20, 12:16AM CST
Seaspan Corp. announced that in connection with its previously announced public offering of its 8.25 percent Series E Cumulative Redeemable Perpetual Preferred Shares, the underwriters have exercised their option to purchase an additional 400,000 Series E Preferred Shares.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading